Patient_Information

We're delighted to launch the inhaler technique videos, which are the first set of patient education videos jointly produced by PrescQIPP and Health and Care Videos. Supporting resources include a technical ...
We are pleased to launch the second of our polypharmacy and deprescribing bulletins - Ensuring Appropriate Polypharmacy. This bulletin covers a strategic overview of polypharmacy and deprescribing and ...
The inhaled therapy in COPD bulletin and briefing has been updated to incorporate the new inhaled therapies licensed to treat COPD. The materials discuss the place in therapy of different inhaled therapies ...
PrescQIPP is pleased to launch two new video resources to support self care work in your area, one for patients and one to share with colleagues. The videos were created in collaboration with Health and ...
This bulletin supports reviewing long term treatment with bisphosphonates and the consideration of treatment break in these patients. A patient information leaflet is available as a supporting resource.  ...
The inhaled therapy in COPD bulletin and briefing has been updated to incorporate the new inhaled therapies licensed to treat COPD.  The materials discuss the place in therapy of different inhaled ...
This DROP-List support bulletin looks at the place in therapy of liothyronine and combination products containing levothyroxine and liothyronine. In light of a limited evidence base supporting its use ...
The rubefacients bulletin supports the PrescQIPP DROP list. It reviews the place in therapy of the rubefacients which also have a nice do not do attached to them. An audit and patient letter are available ...
Created on 22 June 2015
The NSAIDs bulletin and supporting resources look at the risks associated with long term treatment of NSAIDs and also appropriate choice of NSAID.  SystmOne and EMIS searches are available to support ...
This bulletin focuses on the safety concerns accosted with the prescribing of long term PPIs and offers guidance and tools to support reviewing therapy and stepping down or discontinuing treatment in appropriate ...
The Gluten Free guidelines have been updated following feedback from CCGs. Some CCGs requested the addition of multipurpose and bread mixes to the list of prescribable products as although these products ...
  This bulletin and two accompanying briefings look at the issues of ED and PE in men (shortened to avoid your junk mail filters). Advice on prescribing cost effective treatments first line, audit ...
The lutein and antioxidant vitamins bulletin supports the DROP list. It discusses the lack of evidence available to support lutein and antioxidant vitamins as a treatment for the prevention of age related ...
Created on 09 December 2014
This bulletin reviews the place in therapy of rosuvastatin in relation to other statins. Recommendations include advice in the recently updated NICE lipid modification clinical guideline.  Rosuvastatin ...
The gluten free foods guidelines have been updated to include fresh bread as an item recommended for prescribing as surcharges from some suppliers have been significantly reduced.  Gluten ...
The bulletin offers guidance and support material for organisations considering reviewing ISMN prescribing as a QIPP project. The bulletin considers implementation of national guidance from the DH and ...
Created on 30 October 2014
The bulletin focuses on alogliptin which is the fifth dipeptidylpeptidase-4 (DPP-4) inhibitor licensed in the UK. The document includes recommendations to ensure prescribing is in line with NICE guidance, ...
The travel vaccines bulletin and supporting resources will support CCGs wishing to review their prescribing policies on travel vaccines. It identifies those vaccines that should not be prescribed on ...
Created on 23 September 2014
This bulletin provides an overview of the information in the PrescQIPP DROP-List (Drugs to Review for Optimised Prescribing) bulletin on probiotics. It focuses on reviewing prescribing of probiotics ...
This bulletin has been written as an implementation guide for MHRA guidance on which anti epileptic drugs can be switched. Tools are provided to support organisations considering a generic switch for appropriate ...